Clinical trial

Silymarin's Advantage on Graft Effectiveness

NCT06801886

StatusENROLLING_BY_INVITATION

Study typeINTERVENTIONAL

Start date2020-01-07

PhasePHASE3

Study timeline

Study start (actual)2020-01-07Date precision: day

Registry last updated2025-03-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Posttransplant Diabetes Mellitusunresolved

Acute Graft Rejectionunresolved

Biopsy Proven Acute Rejectionunresolved

Antibody Mediated Rejection of Kidney Transplantunresolved

Arterial Hypertension, Chronic Kidney Diseaseunresolved

Interventions

Silymarine supplementationDRUG

Placebo SupplementationOTHER

Sponsors & collaborators

University Hospital, Martinlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06801886 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.